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Background: Leptin plays an important role in the regulation of body weight and 
energy metabolism in adults; its role in neonates also needs to be explored. The 
current study aims to determine the correlation between serum leptin concentra-
tions and anthropometric variables in newborns and their mothers, and to examine 
the effects of sex, gestational age and antenatal steroid use on neonatal leptin 
levels.
Methods: This was a retrospective study. Blood samples were collected from 55 
newborns within 24 hours of birth. Plasma leptin levels were measured by immuno-
metric assay. The relationship between neonatal leptin levels and anthropometric 
parameters was determined using Pearson’s correlation and further evaluated by 
linear regression analysis.
Results: Neonatal leptin was significantly correlated with maternal body weight 
(p < 0.002) and maternal body mass index (BMI) (p < 0.001). However, it was not cor-
related with gestational age (p = 0.130), birth weight (p = 0.097), or birth BMI 
(p = 0.336). The leptin levels in premature newborns (gestational age < 37 weeks; 
0.69 ± 1.82 ng/mL) were significantly less than those in term newborns (gestational 
age ≥ 37 weeks; 2.09 ± 2.30 ng/mL, p = 0.031). There were no significant differences 
between sexes (p = 0.277) or in relation to antenatal steroid use (p = 0.611).
Conclusion: Neonatal serum leptin concentrations within 24 hours of birth corre-
lated with maternal body weight and BMI, especially in premature newborns. 
Premature newborns had significantly lower leptin levels than full-term newborns.
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1.  Introduction
Fetal growth and development are complex pro-
cesses that can be influenced by maternal, placen-
tal, and fetal endocrine factors, which are likely to 
play significant roles in the regulation of nutrient 
utilization and energy metabolism.1 Leptin is a 
16-kDa hormone that is secreted mostly from the 
adipose tissue, placenta, and some fetal tissues.2,3 
It has been extensively studied in recent years due 
to its potential involvements in weight gain and en-
ergy metabolism. While most studies focused on 
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animals or adult humans, the role of leptin in the 
growth and development of newborns, term or pre-
mature remains to be determined.
The principal sites of synthesis and secretion of 
leptin are more widespread than originally thought; 
the stomach, muscle, placenta and fetal tissues 
have all been shown to express leptin, leading to 
the belief that it could play more extensive roles 
in fetal growth and development.3 Some evidence 
has suggested that leptin acts as a fetal growth 
factor that regulates body weight and metabolism 
by acting on the hypothalamic center of satiety.4 
Recent studies in full-term newborns have also in-
dicated that leptin is significantly associated with 
birth weight, body mass index (BMI) and insulin or 
insulin-glucose ratio, suggesting that the adipoin-
sular pathway is active in the full-term newborn.5−7 
Leptin is secreted from adipose tissue; its secre-
tion has been shown to be proportional to body fat 
content, body weight, and gestational age.8 Fur-
thermore, leptin has also been shown to be a stress 
hormone, whose secretion increases in cases of 
fetal distress, maternal diabetes, preeclampsia, 
and with antenatal steroid use.9 It is therefore of 
great interest to determine how leptin concentra-
tions change after delivery, and how they are re-
lated to the nutritional status of mothers and 
newborns.
The aims of the current study are three-fold: 
(1) to evaluate normal leptin concentrations in new-
borns; (2) to determine the correlation between 
newborn serum leptin levels and anthropometric 
variables in mothers and newborns; (3) to examine 
the effects of antenatal steroid use on neonatal 
leptin levels. Through a better understanding of 
leptin, we aim to improve the evaluation of new-
borns’ nutritional status or even manipulate it for 
better weight gain and outcomes.
2.  Materials and Methods
2.1.  Study population
This was a retrospective study. The study protocol 
was approved by the Ethics Committee for Clinical 
Investigation at the Shin Kong WHS Memorial 
Hospital. We prospectively enrolled 58 neonatal pa-
tients who were admitted to the neonatal inten-
sive care unit (NICU) of Shin Kong WHS Memorial 
Hospital between March and September, 2004. These 
patients had suffered respiratory distress requiring 
some degree of resuscitation at birth, and were ad-
mitted to our NICU for further management. Blood 
samples were collected within 24 hours of birth 
and analyzed using standard biochemical methods 
as part of the NICU routine.
Birth body weight (BW), body length, head cir-
cumference, maternal risk factors, the use of steroids 
during the antenatal period and other anthropo-
metric parameters were recorded. BMI was calcu-
lated as body mass, in kg/m2. The decision to 
administer antenatal betamethasone rested entirely 
on the judgment of the attending obstetrician. 
Threatened preterm labor was the management 
criterion for starting antenatal corticosteroid treat-
ment in women before 34 weeks’ gestation. A com-
plete course was defined as two doses of 12 mg 
intramuscular betamethasone given at 24-hour in-
tervals. The study was performed in accordance 
with the Declaration of Helsinki, and written in-
formed consent was obtained from the guardians 
of all participants.
2.2.  Serum leptin analysis
Blood samples were collected within 24 hours of 
birth under fasting conditions. Plasma leptin levels 
were measured using a commercial human leptin 
TiterZyme enzyme immunometric assay kit (Assay 
Designs Inc., Ann Arbor, MI, USA). Samples were 
analyzed in one assay with duplication. The inter-
assay and intra-assay coefficients of variation were 
5% and 10%, respectively.
2.3.  Statistical analysis
Pearson’s correlation was used to assess the rela-
tionships between neonatal leptin levels and the 
anthropometric parameters of both the newborns 
and mothers. Subjects were divided into three 
groups for comparison: premature (< 37 weeks’ ges-
tation) versus term (≥ 37 weeks’ gestation); male 
versus female; and antenatal steroid use versus no 
antenatal steroid use. To compare the plasma lep-
tin levels between groups, t test was used. Trend 
lines in the figures are shown according to the fit-
ted linear regression. Statistical significance was 
accepted at p < 0.05 for all correlations.
3.  Results
Serum leptin concentrations in all newborns were 
significantly correlated with maternal BW (p = 0.002) 
and maternal BMI (p = 0.001) (Figure 1). However, 
there were no correlations between leptin levels 
and other anthropometric parameters such as ges-
tational age, birth BW, body length, head circum-
ference, neonatal BMI, placenta weight, steroid use, 
or maternal height (Table 1).
Premature newborns had significantly lower lep-
tin concentrations (0.69 ± 1.82 ng/mL) than those 
of term newborns (2.09 ± 2.30 ng/mL) (p = 0.031). 
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The leptin levels in premature newborns were sig-
nificantly correlated with maternal BW (p = 0.001) 
and maternal BMI (p = 0.001) (Figures 2A and 2B). 
How ever, leptin levels in term newborns failed to 
show a similar correlation with maternal BW 
(p = 0.901) or maternal BMI (p = 0.481) (Table 2).
Leptin concentrations in females (1.35 ± 2.36 ng/
mL) were higher than those in males (0.67 ± 1.58 ng/
mL), but the difference was not significant (p = 0.277) 
(Table 3). Leptin levels in females were correlated 
with maternal BW (p = 0.020) and BMI (p = 0.010) 
(Figures 3A and 3B). Surprisingly, there was no cor-
relation between leptin concentrations and mater-
nal BW (p = 0.051) or maternal BMI (p = 0.584) in 
males. Instead, leptin levels in males were corre-
lated with birth BW (p = 0.047) (Table 3).
Betamethasone is frequently prescribed to moth-
ers prior to the delivery of premature newborns. 
We divided our subjects into those with and with-
out antenatal steroid use (Table 4). The serum lep-
tin concentrations in those with antenatal steroid 
use (0.78 ± 2.03 ng/mL) were lower than those with-
out steroid use (1.35 ± 1.94 ng/mL), but the differ-
ence was not significant (p = 0.611). Leptin levels 
in those with antenatal steroid use correlated with 
maternal BW (p = 0.002) and maternal BMI (p = 0.002) 
(Figures 4A and 4B).
4.  Discussion
As an adipocyte-secreted hormone, leptin levels in 
the circulation reflect the status of energy stores 
in the brain.4 Leptin alters pituitary function and 
affects numerous extra-neuronal tissues which may 
be responsible for the regulation of energy metab-
olism in the human fetus and neonate. Leptin con-
centration has been found to be positively correlated 
with both BMI and body fat in both lean and obese 
adults.8 Studies have mostly focused on leptin in 
adults or older children. However, very limited in-
formation is available regarding leptin levels and 
their relationships to birth BW, BMI and associated 
risk factors in neonates.
In our study, leptin concentrations showed 
no correlation with birth BW, gestational age, or 
BMI of the neonates. However, leptin concentra-
tions did correlate with the BW and BMI of their 
mothers. Our results are contradictory to that of 
a previous study, which showed that leptin 
concentrations correlated with newborns’ birth 
weights.9 A number of studies suggested that the 
Table 1  Correlation between plasma leptin concen-
trations and anthropometric parameters in 
all newborns
 Estimate*  Parameters
 (n = 55) 
r p
Leptin (ng/mL) 0.99 ± 2.00 1 −
Gestational 33.98 ± 3.15 0.207 0.130 
 age (wk)
Birth weight (g) 2122.93 ± 625.32 0.266 0.097
Length (cm) 43.98 ± 4.95 0.198 0.147
Head 30.60 ± 2.86 0.176 0.199
 circumference (cm)
BMI (kg/m2) 10.74 ± 1.38 0.132 0.336
Placenta weight (g) 657.12 ± 225.40 −0.124 0.403
Steroid use (dose) 1.06 ± 0.96 0.031 0.834
Maternal weight (kg) 67.23 ± 9.39 0.418 0.002†
Maternal height (cm) 159.93 ± 5.21 −0.002 0.991
Maternal BMI (kg/m2) 26.37 ± 3.77 0.466 0.001†
*Values are expressed as mean ± SD; †Pearson’s correlation, 
p < 0.05. BMI = body mass index.
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Figure 1 (A) Correlation between maternal body weight and leptin concentration in all newborns. (B) Correlation 
between maternal body mass index (BMI) and leptin concentration in all newborns. 
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lack of correlation between maternal and neonatal 
leptin levels was due to the drastic reduction 
of maternal serum leptin levels after placenta 
delivery.10,11 Others found that in comparison to 
the leptin released into maternal circulation, the 
leptin released from the placenta into fetal circu-
lation was very low.12 However, adipocytes are not 
the only source of leptin; the placenta also con-
tributes a significant proportion of leptin during 
gestation.13
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Figure 2 (A) Correlation between maternal body weight and leptin concentration in premature and term newborns. 
(B) Correlation between maternal body mass index (BMI) and leptin concentration in premature and term newborns.
Table 2  Correlation between plasma leptin concentrations and anthropometric parameters in premature and 
term newborns
Parameters Premature newborns* (n = 43) p Term newborns* (n = 12) p
Leptin (ng/mL) 0.69 ± 1.82 − 2.09 ± 2.30 −
Gestational age (wk) 32.59 ± 2.12 0.765 38.36 ± 1.28 0.967
Head circumference (cm) 29.71 ± 2.52 0.678 33.43 ± 1.88 0.192
Length (cm) 42.49 ± 3.96 0.928 48.68 ± 4.94 0.896
Birth weight (g) 1916.14 ± 436.39 0.796 2772.86 ± 696.41 0.502
BMI (kg/m2) 10.50 ± 1.25 0.520 11.51 ± 1.52 0.272
Maternal weight (kg) 66.18 ± 8.80 0.001† 70.54 ± 10.74 0.901
Maternal height (cm) 159.44 ± 4.77 0.740 161.63 ± 6.44 0.810
Maternal BMI (kg/m2) 26.08 ± 3.70 0.001† 27.36 ± 4.00 0.481
*Values are expressed as mean ± SD; †Pearson’s correlation, p < 0.05. BMI = body mass index.
Table 3  Correlation between plasma leptin concentrations and anthropometric parameters in male and female 
newborns
Parameters Male* (n = 29) p Female* (n = 26) p
Leptin (ng/mL) 0.67 ± 1.58 − 1.35 ± 2.36 −
Gestational age (wk) 33.48 ± 2.73 0.137 34.56 ± 3.54 0.561
Head circumference (cm) 30.88 ± 2.71 0.070 30.29 ± 3.04 0.615
Length (cm) 43.71 ± 4.65 0.084 44.30 ± 5.35 0.582
Birth weight (g) 2126.61 ± 568.28 0.047† 2118.70 ± 696.14 0.442
BMI (kg/m2) 10.96 ± 1.24 0.312 10.49 ± 1.50 0.428
Maternal weight (kg) 64.98 ± 7.66 0.051 69.64 ± 10.57 0.020†
Maternal height (cm) 160.11 ± 4.48 0.805 159.74 ± 6.01 0.988
Maternal BMI (kg/m2) 25.35 ± 2.79 0.584 27.50 ± 4.42 0.010†
*Values are expressed as mean ± SD; †Pearson’s correlation, p < 0.05. BMI = body mass index.
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Table 4  Correlation between plasma leptin and anthropometric parameters in patients with and without antenatal 
steroid use
Parameters With steroid* (n = 34) p Without steroid* (n = 21) p
Leptin (ng/mL) 0.78 ± 2.03 − 1.35 ± 1.93 −
Gestational age (wk) 31.88 ± 1.81 0.838 36.95 ± 2.05 0.127
Head circumference (cm) 29.44 ± 2.63 0.745 32.25 ± 2.35 0.026†
Length (cm) 41.84 ± 3.82 0.833 47.02 ± 4.83 0.184
Birth weight (g) 1861.18 ± 426.05 0.863 2493.75 ± 681.08 0.054
BMI (kg/m2) 10.52 ± 1.34 0.538 11.05 ± 1.39 0.036†
Maternal weight (kg) 66.42 ± 9.59 0.002† 68.40 ± 9.18 0.771
Maternal height (cm) 159.38 ± 4.01 0.780 160.79 ± 6.66 0.700
Maternal BMI (kg/m2) 26.20 ± 4.06 0.002† 26.62 ± 3.37 0.292
*Values are expressed as mean ± SD; †Pearson’s correlation, p < 0.05. BMI = body mass index.
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Figure 3  (A) Correlation between maternal body weight and leptin concentrations in female and male newborns. 
(B) Correlation between maternal body mass index (BMI) and leptin concentrations in female and male newborns. 
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Figure 4  (A) Correlation between maternal body weight and leptin concentration in newborns with or without ante-
natal steroid use. (B) Correlation between maternal body mass index (BMI) and leptin concentration in newborns with 
or without antenatal steroid use.
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Correlation between serum leptin levels in pre-
mature newborns and maternal BW and BMI could 
be a reflection of maternal nutritional status and 
serum leptin concentrations. The relatively small 
amount of adipose tissue and fat cells could be re-
sponsible for the lower leptin concentrations in 
these premature newborns. Our interpretation is 
that since the premature newborns have little adi-
pose tissue, maternal and placental leptin contrib-
uted to a higher proportion of their serum leptin 
concentration. In comparison, the rapid accumula-
tion of adipose tissue and the higher production of 
leptin in term newborns could easily mask the rel-
atively low concentration of transplacental leptin. 
This could in turn, account for the fact that the 
correlations between serum leptin concentration 
and maternal BW and BMI were only noted in pre-
mature newborns.
Studies have shown that leptin concentrations 
are higher in female neonates than their male 
counterparts.9,14,15 This observed sexual dimor-
phism could be due to the fact that leptin appears 
to be expressed predominantly by subcutaneous 
adipocytes, particularly in females who have more 
subcutaneous adipocytes than males do.16 A number 
of studies have suggested that circulating andro-
gens in males may suppress circulating leptin levels, 
whereas serum estrogen and progesterone may in-
crease leptin levels.8 In the current study, although 
mean leptin concentrations are higher in females 
than males, the difference was not statistically sig-
nificant. This apparent lack of sexual dimorphism in 
leptin concentrations in newborns could be due to 
the relatively small amount of adipose tissue and 
the similarity of tissue composition in both sexes. 
The hormonal profile of male and female infants is 
unlikely to differ at this young age. However, the 
reason for the observed difference in serum leptin 
concentrations remains to be determined.17,18
Previous studies have shown that neonatal serum 
leptin levels were elevated in mothers who had re-
ceived antenatal steroids.19−21 In our study, the 
difference in leptin concentrations between those 
with and those without antenatal steroid use was 
not significant. This could be as a result of the unre-
sponsiveness or low-level response of fetal adi-
pocytes to antenatal steroid stimulation, or 
because the steroids suppressed the transplacen-
tal transport of leptin. As our study design was lim-
ited due to the small sample size, we were not 
able to adequately compare between the with and 
without antenatal steroid use newborns; the aver-
age gestational age and BW varied greatly between 
them. Antenatal steroid use was generally associ-
ated with premature newborns with lower BWs and 
lower leptin concentrations, while those without 
steroid use was associated with older gestational 
age, heavier birth BW, and higher leptin concen-
trations. As a result, the effects of antenatal ste-
roid use on serum leptin concentrations could not 
be easily determined.
The nature of the patients enrolled in this study 
meant that they had been subjected to various de-
grees of stress at birth. Studies have shown leptin 
to be an acute stress-related hormone, whose lev-
els increase in stressful events such as delivery, 
infection, resuscitation, and other medical proce-
dures.22 Although we tried to account for all the 
factors that could affect serum leptin concentra-
tions, other unmeasured maternal conditions, such 
as preeclampsia, gestational diabetes mellitus, or 
infections, could have affected our results.
In conclusion, our data demonstrated that serum 
leptin concentrations in neonates were correlated 
with maternal BW and BMI, especially in premature 
and female newborns. Premature newborns had 
significantly lower leptin concentrations than term 
newborns. These results suggest that maternal and 
placental production of leptin is involved in the 
early regulation of fetal metabolism and growth. 
Further studies are needed however, to clarify the 
role of leptin in the growth and development of 
premature newborns.
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